Lemtrada (Alemtuzumab) for Multiple Sclerosis

What is Lemtrada?
Lemtrada (Alemtuzumab) is a humanized monoclonal antibody used to treat people with Relapsing Remitting Multiple Sclerosis (RRMS) who typically have not responded to 2 or more treatments. It is technically a type of chemotherapy as it was originally released as Campath (first FDA approved in 2001) to treat B-cell Chronic Lymphocytic Leukemia (B-CLL) but was used at a much higher dose (Campath). It was later FDA approved for treating Multiple Sclerosis on Nov 14, 2014.

Is Lemtrada Chemo? Click Here to Read!

How Does Lemtrada Work?

First let’s briefly explore the role of the immune system in Multiple Sclerosis and what a Humanized Monoclonal Antibody is/does. Multiple Sclerosis is believed to be an autoimmune disease in which the body’s own immune system attacks itself (the Myelin Sheath in the case of MS).

Read more

Finally, Some Tangible Evidence of Raynaud’s Phenomena

For the last few years, I started getting really cold hands and feet. I used to be able to hold my hand in a bucket of ice water longer than all my friends (growing up) but now when it get’s just a little cold outside my hands feel like they are going to fall off! Even if the rest of me feels hot my hands and feet are freezing! My ex-girlfriends would always get mad at me when I accidentally would bump my feet into them first thing in the morning; no one likes to be woken up by the feeling of something ice cold pressing against their skin!

Read more